BCR-AblSilencing by siRNA: A Potent Approach to Sensitize Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitor Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BCR-AblSilencing by siRNA: A Potent Approach to Sensitize Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitor Therapy

Published:2019-06 Issue:11 Volume:28 Page:734-744
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

KC Remant¹,Thapa Bindu²,Ubeda Anyeld³,Jiang Xiaoyan⁴,Uludağ Hasan¹²³

Affiliation:

1. Department of Chemical & Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Canada.

2. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.

3. Department of Biomedical Engineering, Faculty of Medicine, University of Alberta, Edmonton, Canada.

4. Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2018.0196

Reference50 articles.

1. The molecular biology of chronic myeloid leukemia

2. Chronic myeloid leukaemia as a model of disease evolution in human cancer

3. Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders

4. Unique Forms of the abl Tyrosine Kinase Distinguish Ph 1 -Positive CML from Ph 1 -Positive ALL

5. Molecular biology of bcr-abl1–positive chronic myeloid leukemia

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia;ACS Pharmacology & Translational Science;2024-08-15

2. Cell-penetrating peptide and cationic liposomes mediated siRNA delivery to arrest growth of chronic myeloid leukemia cells in vitro;Biochimie;2024-06

3. Advancements and Future Prospects in Molecular Targeted and siRNA Therapies for Chronic Myeloid Leukemia;Biomolecules;2024-05-30

4. Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models;Journal of Controlled Release;2024-03

5. Cell-penetrating peptide and cationic liposomes mediated siRNA delivery to arrest growth of chronic myeloid leukemia cellsin vitro;2023-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3